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Glioblastoma multiforme (GBM) is a highly malignant human brain tumour for which no cure is available at present. Numerous clinical studies
as well as animal experiments are under way with the goal being to understand tumour biology and develop potential therapeutic approaches. C6
cell glioma in the adult rat is a frequently used and well accepted animal model for the malignant human glial tumour. By combining standard
analytical methods such as histology and immunohistochemistry with Fourier Transform Infrared (FTIR) microspectroscopic imaging and
multivariate statistical approaches, we are developing a novel approach to tumour diagnosis which allows us to obtain information about the
structure and composition of tumour tissues that could not be obtained easily with either method alone. We have used a “Stingray” FTIR imaging
spectrometer to analyse and compare the compositions of coronal brain tissue sections of a tumour-bearing animal and those from a healthy
animal. We have found that the tumour tissue has a characteristic chemical signature, which distinguishes it from tumour-free brain tissue. The
physical-chemical differences, determined by image and spectral comparison are consistent with changes in total protein absorbance,
phosphodiester absorbance and physical dispersive artefacts. The results indicate that FTIR imaging analysis could become a valuable analytic
method in brain tumour research and possibly in the diagnosis of human brain tumours.
© 2006 Elsevier B.V. All rights reserved.Keywords: Animal model; Brain tumour; Focal plane array detector (FPA); Fourier transform infrared (FTIR) micro-spectroscopy1. Introduction
Fourier transform infrared (FTIR) spectroscopy has been
applied to numerous cell and tissue samples, however, the
technique is still primarily a research tool and direct clinical
applications are few. With the advent of multi-array detectors
and sophisticated data analytical techniques including multi-
variate methods and neural networks this situation is bound to
change. Recent advances in focal plane array technology have
provided a powerful multi-channel infrared detector, which
when coupled with a rapid scan FTIR instrument and its⁎ Corresponding author.
E-mail address: bayden.wood@sci.monash.edu.au (B.R. Wood).
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doi:10.1016/j.bbamem.2006.05.004multiplexing advantage, enables the simultaneous, fast acqui-
sition of a high number of spectra at essentially diffraction
limited spatial resolution. Each spectrum can be correlated to a
particular x–y coordinate and for tissue samples this provides a
powerful molecular imaging tool for pathology. The images can
be presented in various ways with the simplest way being
chemical images where the intensity, or relative intensity of
bands associated with macro-molecular components provides
the contrast in false colour maps. Cluster analysis, and in
particular unsupervised hierarchical cluster analysis (UHCA)
can be used to group similar spectra (i.e. regions with similar
macromolecular chemistry) into groups or clusters. The
resulting false-colour maps generated from cluster analysis or
chemical imaging can be directly compared to stained sections
to assist in identifying both anatomical and histopathological
features at the molecular level.
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chemometric based analysis for tumour detection and classifi-
cation of tissue samples including cervical [1–5], oral mucosa
[6,7], skin [8,9], lymph [10,11], prostrate [12,13], colon [14–
16], lung [17], and breast [18,19]. Fewer studies have focussed
on brain tissue, with some notable exceptions being investiga-
tions of multiple sclerosis plaques [20,21] and scrapie infections
of the central nervous system [22,23]. More recently a study
utilised FTIR imaging and chemometrics to diagnose astrocytic
glioblastoma tissue in human brain sections and demonstrated a
64% classification success rate when various chemometric
models were combined to provide an aggregated prediction
model [24]. Raman micro-spectroscopy has also been applied to
investigate water content [25] and radiation damage in brain
tissue [26] but the time required to build maps from Raman
measurements renders this technique unsuitable for clinical
analysis at present.
C6 cell glioma is a frequently used animal model for
glioblastoma multiforme (GBM), a highly malignant human
brain tumour, for which no cure is available at the present. The
average survival after presentation with clinical symptoms from
GBM is 1.5 years. The C6 cell glioma model is often used for
experiments during the pre-clinical stage to test novel
therapeutic approaches that might increase the recurrence-free
survival time for human patients with GBM.
C6 is a commercially available tumour cell line, with the
advantage that the tumour cells have been raised in rats and
therefore no immunosuppression is required to allow implanted
tumour cells to multiply in the brain of rats as host animals. A
second advantage is that C6 gliomas exhibit characteristics
equal or very similar to those found in human malignant glioma.
Implanted glioma cells multiply in the rodent brain and form an
irregularly shaped solid tumour of 2.5–4 mm within 2 weeks
after implantation. If no therapy is given between weeks 2 and 3
after C6 cell implantation, the animals usually die as a
consequence of increased intracranial pressure. Some of the
tumour cells migrate to brain regions distant from the local
tumour bulk [27].
The aim of the project was to (a) study the composition of
healthy brain structures, (b) identify spectra characteristic for
malignant brain tumours and (c) search for spectral changes
caused by the presence of malignant tumours on the adjacent
brain tissue.
2. Materials and methods
Two adult male Wistar rats were used for our studies. One rat served as host
for a brain tumour and one rat was used as an age-matched healthy control. The
animals were housed and cared for in a temperature-regulated animal facility
exposed to a 12-h light/dark cycle in accordance with the guidelines of the
Canadian Council on Animal Care. To generate the brain tumour, C6 cell
cultures were expanded to confluence, harvested and stored in an ice bucket.
Anaesthesia was achieved in the host animal with 5% Halothane® in oxygen
with a flow rate of 1.5 l/min for induction and 2% Halothane® with the same
oxygen flow rate for continuation of anaesthesia. A subcutaneous injection of
0.05 mg Buprenorphine®/kg was administered as premedication and served,
considering the shortness of the surgical procedure, also the purpose of post-
surgical analgesia. The head of the animal was shaved and disinfected with
Hibitane® (chlorhexidine) and 70% alcohol. A straight parasagittal incision ofskin and periosteumwas performed about three mm to the right of the midline. A
burr hole of 0.6 mm diameter was placed three mm behind the coronary suture.
About 100,000 C6 cells were suspended in a total volume of 5 μl Hank's
solution and loaded in a Hamilton syringe. To assure that the tumour cell
injection caused a minimum of trauma to the brain, the Hamilton syringe was
attached to a syringe pump (KDS 310, Geneq, Canada). The cells were injected
over a period of 2 min into the anterior part of the right brain hemisphere of the
anaesthetized animal. At the end of the injection procedure, the burr hole in the
skull bone was closed with a plug of bone wax and the skin was sutured. The
animal was allowed to recover. It was sacrificed 2 weeks after C6 cell
implantation, at which time an irregularly shaped tumour mass had developed in
the right cerebral hemisphere (diameters of 2.5–4 mm). Both animals were
sacrificed under Halothane® anaesthesia by intracardiac perfusion with normal
saline (1 ml/g rat) and 10% Formalin (1 ml/g rat). The brains were isolated,
stored in 10% Formalin overnight and processed for embedding in paraffin.
Coronal sections of 4 μm thickness were mounted alternately on either
superfrost® slides (VWR) or IR reflecting slides (MIRR-IR, Kevley
Technologies, OH, U.S.A.). The sections mounted on MIRR-IR slides were
de-paraffinised in a xylene bath for 3 min and then air-dried. The xylene
treatment presumably greatly reduces the phospholipid content of the tissue
samples. While cryo-microtomed sections might offer spectroscopic information
on lipid content that is largely lost through the paraffin embedding procedure it
was thought that cryo-sectioning to 4 μm thickness would make the production
of histologically presentable sections extremely difficult. Sections on the
superfrost® slides were stained with Hematoxylin and Eosin (H&E).
IR spectra were acquired at the Centre for Biospectroscopy at Monash
University in Melbourne, Australia, using a “Stingray” FTIR microscope system
(Varian Inc.) equipped with a mercury cadmium telluride (MCT) 64×64 focal
plane array (FPA). Spectra were recorded in reflection/absorption mode at
6 cm−1 resolution over the region 4000–900 cm−1. The samples were imaged as
1024-tile (32×32) mosaics which covered an 11.26×11.26 mm area at a
nominal pixel spatial resolution of 88 μm. The resulting FTIR images were
processed using CytoSpec [28] spectroscopic software. The spectra contained in
each image pixel were then subjected to a quality test and those pixels which
passed were then further processed in CytoSpec to generate both chemical
images (chem-images) and UHCA maps. Each of the chem-images plots image
intensity as a function of the integrated area under a chosen spectral band after
subtraction of the local baseline. By choosing to plot integrated band areas as
opposed to absorbance at a single wavenumber the chem-images produced are
less influenced by baseline effects and band shifts. The UHCA maps were
produced using CytoSpec and the UHCA analysis was performed on the second
derivatives of the spectra contained within the images. The UHCA was
performed on the spectral region 1800–900 cm−1, which includes the amide
region (1700–1250 cm−1), the νas PO2− region (1250–1200 cm
−1) and the νas
C–O region (1060–1000 cm−1). UHCA collects similar spectra into groups or
clusters. The resulting false-colour cluster maps were directly compared with the
H&E stained sections to assist in identifying both anatomical and histopath-
ological features.
3. Results
3.1. Histology
H&E stained visible light micrographs of the healthy rat
brain and a brain containing the malignant glioma are shown in
Figs. 1a and b. In the micrograph of healthy brain various
anatomical structures can be readily identified, such as, the
cortex, the caudoputamen, the corpus callosum, the septal
nucleus and the anterior commissure. Also easily identifiable
are the myelinated fibres running perpendicular to the plane of
the section through the caudoputamen, which give the region its
characteristic spotted appearance. In the brain section of the
tumour–bearing animal the primary tumour site within the
caudoputamen is clearly visible in the right hemisphere, just
below the corpus callosum. As a consequence of the tumour
Fig. 2. Chem-images representing the distribution of amide I, (1620–1680 cm−1
integrated peak areas after baseline correction), in the healthy brain (a) and in the
brain with the malignant glioma (b). Red indicates regions of highest absorbance
and blue indicates regions of lowest absorbance.
Fig. 1. Coronal sections of healthy rat brain (a) and brain with the malignant
glioma (b). H&E stain, low magnification. FC: site of Falx cerebri (interhemi-
spherical fissure), AC: anterior commissure, CC: corpus callosum; LV: lateral
ventricle; SN: septal nucleus, R: right hemisphere; L: Left hemisphere.
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have been compressed and midline-structures have been shifted
towards the left. Infiltration of the tumour into the basal ganglia
can be detected at low–medium magnification under the light
microscope.
3.2. Protein region
The chem-images shown in Fig. 2 present the distribution of
the amide I band (1700–1570 cm−1) due to proteins within
coronal sections of the healthy brain (a) and the brain containing
the malignant glioma (b). All the chem-images presented here
were produced by plotting final image intensity as proportional
to the integrated area under the band of interest after subtraction
of the local baseline. In the healthy brain the highest relative
concentrations of proteins were found in the corpus callosum,
and in various regions of the basal ganglia. The chem-image
shows relatively low absorbance from amide I in most of the
cortex. However, higher amide I absorbances were observed in
an outer layer of the cortex, to a depth of approximately 300 μm.
In the brain section of the tumour-bearing rat, the highest
absorbances due to amide I were recorded at the site of the
tumour. Interestingly, in the brain section of the tumour-bearinganimal the corpus callosum showed lower absorbance at the
amide I band compared to that in the cortex and the
caudoputamen, in contrast to the result for the healthy brain.
3.3. Phosphodiester region
The chem-images in Fig. 3 present the absorbance
distribution of the band at 1235 cm−1 mostly due to symmetric
vibrations of phosphodiester groups of RNA and DNA. In the
healthy brain sample the highest relative phosphodiester group
absorbances were recorded in the medial region of the corpus
callosum, in the commissure anterior and on a medial line
through the basal ganglia. Intermediary absorbances were
recorded for the lateral regions of the corpus callosum and
within the caudoputamen. Most of the cortex appears to have
the lowest relative phosphodiester absorbances. In the brain
section of the tumour-bearing animal the highest phosphodiester
absorbances were recorded in the tumour growth, with
progressively lower absorbances in the cortex and the corpus
callosum.
Fig. 4. UHCA maps generated for two clusters using the 900–1800 cm−1
spectral window, in the healthy brain (a) and in the brain with the malignant
glioma (b). (c) Average cluster spectra from two cluster UHCA spectra colour
coded to enable comparison with the cluster maps.
Fig. 3. Chem-images representing the distribution of phosphodiester, (1200–
1270 cm−1 integrated peak areas after baseline correction), in the healthy brain
(a) and in the brain with the malignant glioma (b). Red indicates regions of
highest absorbance and blue indicates regions of lowest absorbance.
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Fig. 4 shows the cluster maps obtained when UHCA was
performed on the healthy brain (a) and the brain containing the
tumour (b) to produce just two clusters. For the two cluster
UHCA of the healthy tissue section the white and grey matter
areas are separately clustered. The two clusters UHCA of the
tissue section of the tumour-bearing animal separated the tu-
mour into one cluster and the non-tumorous tissue into the other.
Fig. 4c shows the four mean spectra obtained by averaging
the collected spectra from each of the clusters. These four
spectra are presented baseline corrected and vector normalised
to remove absorbance variation that may be due solely to small
differences in sample thickness of the two different tissue
sections. The two spectra from the clusters in the healthy sample
are very similar. However, the spectrum corresponding to the
white matter exhibits slightly increased absorbance in the amide
I and amide II bands from proteins and increased absorbance
at the lower wavenumber end of the spectrum (particularly
around the phosphodiester bands at 1235 and 1078 cm−1) whencompared to the spectrum corresponding to the grey matter. An
increased absorbance at the lower wavenumber part of the
spectra was also recorded for the two spectra obtained from the
brain section of the tumour-bearing animal. The spectrum
obtained from the cluster corresponding to the tumour exhibits a
markedly decreased amide I/amide II ratio, a slight shift of the
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bance increase in the bands due to phosphodiester vibrations.
Figs. 5a and b show the cluster maps obtained when UHCA
was performed to produce maps containing eight clusters on the
same tissue samples. At eight clusters many anatomical features
can be identified in the healthy brain sample. Five layers are
distinguishable in the cortex (yellow–orange–brown–green–
brown) that may correspond to the outermost Brodmann layers.
Three of the eight clusters (very-pale blue, red and yellow)
corresponded to poor quality spectra that exhibited strong
evidence of the dispersive artefact. This is not surprising as
these cluster areas are located on the edge of the tissue sample
and around holes in the tissue. The five remaining clusters
correspond well with the tissue structures as follows; a cluster
corresponding to the Brodmann layer IV in the cortex (green), a
cluster containing an inner layer of the cortex and the grey
matter areas in the caudoputamen (brown), a cluster for the
white matter spots in the caudoputamen and most of the basal
ganglia (orange), a cluster located in the lateral portions of the
corpus callosum (light blue), and lastly, a cluster located at the
medial portion of the corpus callosum, the commissure anterior
and a medial spot in the basal ganglia (dark blue). The average
spectra obtained from these five clusters have very similar
profiles but changing total absorbance levels as can be seen in
Fig. 5c.Fig. 5. UHCA maps generated for eight clusters using the 900–1800 cm−1 spectral w
Collected mean cluster spectra from eight cluster analyses, spectra colour coded to en
with the malignant glioma (d).The UHCA at eight clusters on the tumour sample spectra
produced only three clusters that contained good quality spectra
and corresponded with identifiable tissue structures. These three
clusters were at locations corresponding to a large fraction of the
tumour (pale green), the corpus callosum (pale blue) and most of
the remainder of the non-tumorous fraction of the tissue section
(brown). The average cluster spectra from these three clusters are
shown in Fig. 5d. The spectrum from the caudoputamen differs
from the spectrum of the remaining non-tumorous tissue fraction
in that the caudoputamen spectrum exhibits reduced absorbance
in the amide I and amide II protein bands. The tumour cluster
spectrum has slightly increased absorbance at the lower
wavenumber end of the spectrum when compared with the
spectrum from the non-tumorous tissue fraction, particularly
around the 1070 cm−1 band due to symmetric phosphodiester
vibrations. The tumour cluster spectrum also exhibits a slight
shift towards lower wavenumber and a slight broadening of the
amide I band.
4. Discussion
The FTIR imaging and UHCA approach employed in this
study was able to readily identify the tumour growth as
chemically distinct from the surrounding brain tissue. The
tumour and surrounding tissue were immediately separated atindow, in the healthy brain (a) and in the brain with the malignant glioma (b).
able comparison with the cluster maps, for the healthy brain (c) and in the brain
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maps the invasive portion of the tumour is clearly apparent,
even more so than in the visible light micrographs.
UHCA of the FTIR images was also able to isolate and
classify cluster average spectra for many of the brain structures
present in the healthy brain tissue sample. These healthy tissue
clusters showed very similar spectral profiles and varied mainly
in total absorbance. The prominent bands observed included (a)
amide I (∼1650 cm−1) and amide II (∼1544 cm−1) vibrations
from proteins, (b) the acyl deformation modes from peptide side
chains (∼1460 cm−1) (c) the COO− stretching vibration at
1400 cm−1 mainly from amino acid side chains, (d) the
asymmetric phosphodiester vibration around 1235 cm−1 from
nucleic acids, (e) a band at around 1165 cm−1 due to symmetric
C–O vibrations possibly originating from RNA and/or carbohy-
drates, and finally, (f) a broad spectral feature extending from
1030 to 1130 cm−1 most likely comprised of contributions from
C–O stretching vibrations from ribose C–O skeletal vibrations
in RNA and DNA and a strong contribution from the symmetric
stretching vibration of phosphodiester groups in nucleic acids.
Thus, the majority of the dominant bands in the spectra arise
from proteins and nucleic acids. The changing total absorbance
observed in the different cluster spectra obtained from the
healthy brain tissue types might therefore be well explained as a
simple measure of the ratio of proteins, DNA and ribosomal
RNA versus the cellular cytoplasm fraction, with the highest IR
absorption appearing in those tissue types with the greatest
amount of protein content per unit tissue volume. It appears
likely that the differing degrees of myelination present in the
different brain structures is also being detected through its
influence on the total protein content. The clustering in Fig. 4a
shows distinction in regions with high myelin content (brown)
versus regions with low myelin content (pale blue). The UHCA
has distinguished between densely packed myelinated tracts
(dark blue: corpus callosum and anterior commissure), morpho-
logically less densely packed myelinated tracts (lighter blue:
cingulum, external capsule and septal nucleus) and radiating
myelinated fibres (orange in the caudoputamen and septal/fornix
region).
The cluster analysis also appears to be identifying layers in
the cortex, which correspond well with the six anatomical
Brodmann layers of the neocortex. The Brodmann layers
describe anatomical layers according to the cellularity, with
higher and lower content of cell bodies. The cells of the outer
cortical layer (layer I corresponding to the yellow cluster) have
a low cytoplasmic/nuclear ratio. However, it is important to
note that because of the proximity of this layer to the outer
edge of the tissue other physical effects such as dispersion
could also explain its separation from the more internal layers.
Cell bodies with higher cytoplasmic/nuclear ratios are
concentrated in layers II (orange), III, V and VI (brown). The
third and fifth layers of the amide I chem-image (Fig 2a) show
a similar amide I absorbance distribution; Brodmann layers III
and V are both characterized by a high content of pyramidal
cells (external and internal pyramidal layer). The relatively
wide layer IV (green) corresponds to the internal granular
layer, which contains only few neuronal bodies and is mostlycomposed of dendritic and axonal connections between cell
bodies.
UHCA revealed spectral changes between the non-tumorous
and the tumour tissues present in the section of the tumour-
bearing animal. An increase in relative absorbance of most
bands was observed for the tumour spectra that may be
explained by an increase in the fractional content of proteins in
the tumour cells compared to the unaffected cells. The tumour
spectra also showed a slight decrease in the ratio of peaks
heights from amide I/amide II, a shift in the amide I band toward
lower wavenumber and a broadening of the amide I band.
Recent articles [11,29,30] have described a dispersive artefact
which can arise in reflection/absorption measurements and an
artefact due to a Mie-type scattering mechanism, both of which
can lead to non-Beer–Lambert absorption behaviour in infrared
microspectroscopic observations of biological samples. It is not
uncommon for the amide I band to be observed shifted towards
lower wavenumber and reduced in height solely as a result of
the dispersion artefact. Inspection of the spectral baselines
showed little or no evidence of Mie-type scattering. However, at
the edges of the tissue and within a few microns of holes in the
tissue some distortion of the spectra was apparent, probably as a
result of the dispersion artefact. To ensure that the integrated
area of the amide I mode is representative of changes in protein
concentration and not physical artefacts chem-images were
produced that plotted image intensity as a function of the ratio
of integrated, baseline corrected, amide I/amide II absorbances.
The chem-images produced were found to be uniform and
featureless across the vast majority of the tissue contained in the
samples. As the total amide I/amide II absorbance was a
constant throughout the majority of the sample we conclude that
physical artefacts resulting in non-specific matrix type absorp-
tions had little or no impact on the technique's ability to
measure real changes in protein concentration based on the
integrated intensity of the amide I mode. However, care must be
taken when interpreting the shift observed in amide I band for
the tumour spectra to ensure one is reporting a real chemical
shift and not just a product of a physical artefact such as
dispersion. The non-normalised mean extracted spectra pre-
sented in Fig. 5b appear to contain a mixture of different degrees
of dispersion artefacts as they show a correlation between lower
absorbance and red shifted wavenumber for the amide I mode,
indicative of some physical effect contributing to the position of
this band. Consequently, those cluster maps generated over the
1800–950 cm−1 range would appear to be based on spectral
variation associated with physio-chemical differences as
opposed to chemical differences alone. It would also appear
that the major differences between clusters are based on
variation associated with protein concentration and possible
physical effects resulting in shifts in the amide I mode.
Nonetheless, the cluster maps do show more detail and apparent
information than the H&E stained sections. For instance it is
clear from the cluster map presented in Fig. 4b that there is a
narrow section of cells connecting the two tumorous masses
together, which is not apparent in the visible image. Fig. 4c
compares spectra collected from the tumour sample with spectra
from the healthy sample. The spectra from the non-tumorous
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observed to have increased absorbance around the phospho-
diester bands compared to the spectra obtained from the healthy
sample. At the eight clusters level several of the different tissue
types present in the healthy sample were clearly separated by
the UHCA, which was not the case for the tumour sample,
where apart from the corpus callosum no tissue type
differentiation was obtained from the UHCA. In the tumour
sample the amide and phosphodiester absorbances in the corpus
callosum were lower than for the corresponding bands in the
surrounding tissue while for the healthy sample these two
absorbance bands were stronger than in the other tissue types.
Taken in combination these spectral changes indicate that FTIR
imaging is capable of detecting physical–chemical differences
from healthy tissue in the tumour sample at all points within the
brain, not just at the site of the tumour growth itself.
It is interesting to note that in the eight cluster analysis the
corpus callosum in the healthy sample was divided into two
clusters, one cluster for the medial part and one cluster for the
lateral zones. The site of the division of these clusters corre-
sponds to the location of the feature known as the cingulum
bundle.
UHCA is able to differentiate clusters based on spectral
features that are sometimes extremely difficult to discern from
the spectra by eye alone. For optimal results, the analysis of
brain sections from healthy and tumour-bearing animals should
be performed in the same data set. Unfortunately, that is not yet
possible due to limitations in computer capacity. However, we
have shown that FPA-based IR analysis of brain tissue in an
animal model of malignant brain tumour can supply useful
information with regard to the chemical composition of
complex tissues that cannot be obtained otherwise.
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